As of 2024-12-13, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (20.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.56 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -315.5%.
The range of the Relative Valuation is (11.62) - (27.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 25.2x | 18.5x |
| Forward P/E multiples | 10.0x - 25.8x | 18.6x |
| Fair Price | (11.62) - (27.99) | (20.60) |
| Upside | -221.6% - -392.8% | -315.5% |
| Date | P/E |
| 2024-12-11 | -8.62 |
| 2024-12-10 | -8.51 |
| 2024-12-09 | -8.43 |
| 2024-12-06 | -8.68 |
| 2024-12-05 | -8.28 |
| 2024-12-04 | -8.55 |
| 2024-12-03 | -8.56 |
| 2024-12-02 | -8.81 |
| 2024-11-29 | -8.92 |
| 2024-11-27 | -9.07 |
| 2024-11-26 | -8.79 |
| 2024-11-25 | -8.20 |
| 2024-11-22 | -7.96 |
| 2024-11-21 | -7.68 |
| 2024-11-20 | -7.92 |
| 2024-11-19 | -8.04 |
| 2024-11-18 | -7.84 |
| 2024-11-15 | -8.26 |
| 2024-11-14 | -8.95 |
| 2024-11-13 | -9.56 |
| 2024-11-12 | -9.56 |
| 2024-11-11 | -9.88 |
| 2024-11-08 | -10.01 |
| 2024-11-07 | -9.72 |
| 2024-11-06 | -9.87 |
| 2024-11-05 | -9.53 |
| 2024-11-04 | -9.26 |
| 2024-11-01 | -9.37 |
| 2024-10-31 | -9.50 |
| 2024-10-30 | -9.99 |
| 2024-10-29 | -10.19 |
| 2024-10-28 | -10.25 |
| 2024-10-25 | -10.05 |
| 2024-10-24 | -9.82 |
| 2024-10-23 | -9.79 |
| 2024-10-22 | -10.19 |
| 2024-10-21 | -10.25 |
| 2024-10-18 | -10.22 |
| 2024-10-17 | -10.00 |
| 2024-10-16 | -10.34 |
| 2024-10-15 | -9.23 |
| 2024-10-14 | -9.43 |
| 2024-10-11 | -8.82 |
| 2024-10-10 | -8.31 |
| 2024-10-09 | -8.39 |
| 2024-10-08 | -8.40 |
| 2024-10-07 | -8.55 |
| 2024-10-04 | -8.87 |
| 2024-10-03 | -8.32 |
| 2024-10-02 | -8.40 |